$CBIO 4 SEC Filings

Filed On	Filing
18 Sep 2026	Form 4: Lynch Ryan, See Remarks Sold 240 shares ($4.3K)
18 Sep 2026	Form 4: Pinkas Jan, Chief Scientific Officer Sold 658 shares ($11.8K)
18 Sep 2026	Form 4: Im Ellie Eunkyung, Chief Medical Officer Sold 623 shares ($11.2K)
18 Sep 2026	Form 4: Scalzo Richard William, Chief Financial Officer Sold 568 shares ($10.2K)
18 Sep 2026	Form 4: Bispham Barbara Harlin, See Remarks Sold 620 shares ($11.1K)
18 Sep 2026	Form 4: Brumm Joshua T, Director Sold 1,610 shares ($28.8K) · Sold 7,837 shares ($131K)
18 Sep 2026	Form 4: McNeill Jonathan, President and COO Sold 731 shares ($13.1K) · Sold 3,839 shares ($64.1K)
20 Jul 2026	Form 4: Fairmount Funds Management Llc, Director and 3 others Bought 853,450 shares ($12.4M) · Acquired 525,897 Pre-Funded Warrant (Right to Buy) (Open Market Purchase) ($7.62M)
23 Jun 2026	Form 4: Lynch Ryan, See Remarks Sold 465 shares ($8.37K)
23 Jun 2026	Form 4: Pinkas Jan, Chief Scientific Officer Sold 1,288 shares ($23.2K)
23 Jun 2026	Form 4: Scalzo Richard William, Chief Financial Officer Sold 1,112 shares ($20K)
23 Jun 2026	Form 4: Bispham Barbara Harlin, See Remarks Sold 1,218 shares ($21.9K)
23 Jun 2026	Form 4: Im Ellie Eunkyung, Chief Medical Officer Sold 1,219 shares ($21.9K)
23 Jun 2026	Form 4: McNeill Jonathan, President and COO Sold 20,549 shares ($370K)
23 Jun 2026	Form 4: Brumm Joshua T, Director Sold 42,305 shares ($761K)
03 Jun 2026	Form 4: Violin Jonathan, Director Granted 11,050 Stock Option (Right to Buy)
03 Jun 2026	Form 4: Lubner David Charles, Director Granted 11,050 Stock Option (Right to Buy)
03 Jun 2026	Form 4: Balcom Alexandra, Director Granted 11,050 Stock Option (Right to Buy)
03 Jun 2026	Form 4: Moran Susan, Director Granted 11,050 Stock Option (Right to Buy)
03 Jun 2026	Form 4: Fairmount Funds Management Llc, Director and 3 others Granted 11,050 Stock Option (Right to Buy)

Comments